Cultural Adaptation, Validity, and Reliability of the Turkish Version of The PASTUL Questionnaire
Recruiting
Observational Study
Systemic Sclerosis (SSc)
Systemic Sclerosis (Scleroderma)
Scleroderma (Limited and Diffuse)
Patient Perspective
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 50 (estimated)
- Sponsor
- Hacettepe University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The Patient Self-Assessment of Skin Thickness in Upper Limb (PASTUL) questionnaire was developed to enable patients to assess skin thickness in systemic sclerosis (SSc) physically and has been validated for reliability and validity, as it correlates with the modified Rodnan Skin Score (mRSS), which rheumatologists assess. Thus, it has been demonstrated to be an applicable and easy approach for ass…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Individuals diagnosed with scleroderma,
* Individuals aged 18 years and older
Exclusion Criteria:
* Advanced heart/lung/liver/kidney disease, neurological disease, and malignancies
* Individuals who are unwilling to participate
Contacts